montelukast | Montelar tablets coated. 10 mg, 28 pcs.

Release form

Film-coated tablets.

Packing

28 pcs.

Pharmacological action

Montelar - blocker of cysteinyl leukotriene receptors CysLT1 (leukotrienes C4, D4 and E4 - mediators of chronic persistent inflammation, supporting bronchial hyperresponsiveness in bronchial asthma).

Prevents excessive secretion in the bronchi, swelling of the mucous membrane of the respiratory tract. Reduces the severity of bronchial asthma and the frequency of asthmatic attacks. Highly effective when taken orally.

Bronchodilator action develops within 1 day and lasts a long time.

Effective in patients with mild persistent asthma, not sufficiently controlled by bronchodilators alone.

Contraindications

Hypersensitivity, children's age (up to 6 years).

Caution. Pregnancy, lactation.

Special instructions

It is recommended that you continue to take it after you have achieved a significant improvement.

Should not be used to relieve acute asthmatic attacks, does not replace inhaled bronchodilators.

Composition

1 tablet contains 10 mg montelukast.

Dosage and Administration

Inside, regardless of food intake.

Adults and teenagers over 15 years of age - 10 mg once a day, at bedtime.

Side effects

abdominal pain, headache, nausea, flu-like syndrome, cough, sinusitis, pharyngitis, increased activity of hepatic transaminases, allergic reactions.

Storage conditions

In a place protected from light and moisture, at a temperature not exceeding 30 РC.

Keep out of the reach of children.

Expiration

2 years.

Active ingredient

Montelukast

Conditions for the drugstore from

By recipe

Dosage form

tablets

Appointment

Children by doctor's appointment, Adults by doctor's appointment, Children over 15 by

Indications

Bronchitis, From respiratory tract infections, From boils, From otitis, From pyoderma, From sore throat, From cystitis, From urethritis, From urinary tract infections, From skin infections, From pharyngitis8 onhospazm, Bronhyalnaya asthma

Sandoz, Switzerland